bq 610 has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitamuro, T; Murakami, O; Shibahara, S; Sone, M; Takahashi, K; Totsune, K | 1 |
| Fukami, T; Ihara, M; Ishikawa, K; Ohwaki, K; Ozaki, S; Towers, P; Yamanaka, R; Yano, M | 1 |
2 other study(ies) available for bq 610 and Neuroblastoma
| Article | Year |
|---|---|
Three vasoactive peptides, endothelin-1, adrenomedullin and urotensin-II, in human tumour cell lines of different origin: expression and effects on proliferation.
Topics: Adrenal Cortex Neoplasms; Adrenomedullin; Antibodies, Monoclonal; Cell Division; Choriocarcinoma; Colonic Neoplasms; Endothelin Receptor Antagonists; Endothelin-1; Glioblastoma; Growth Substances; HeLa Cells; Humans; Kidney Neoplasms; Neuroblastoma; Oligopeptides; Peptides; Piperidines; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Tumor Cells, Cultured; Urotensins; Vasodilator Agents | 2002 |
[3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype.
Topics: Amino Acid Sequence; Azepines; Binding, Competitive; Endothelin Receptor Antagonists; Endothelins; Humans; Indoles; Isotope Labeling; Molecular Sequence Data; Neuroblastoma; Oligopeptides; Peptides, Cyclic; Radioligand Assay; Receptor, Endothelin A; Receptors, Endothelin; Structure-Activity Relationship; Tritium; Tumor Cells, Cultured | 1995 |